1. Signaling Pathways
  2. Anti-infection
  3. Antibiotic
  4. Oxazolidinone Isoform

Oxazolidinone

 

Oxazolidinone Related Products (15):

Cat. No. Product Name Effect Purity
  • HY-10394
    Linezolid
    99.95%
    Linezolid (PNU-100766) is the first member of the class of oxazolidinone synthetic antibiotic.
  • HY-14855
    Tedizolid
    99.19%
    Tedizolid (TR 700; Torezolid; DA-7157) is a novel oxazolidinone, acting through inhibition of bacterial protein synthesis by binding to 23S ribosomal RNA (rRNA) of the 50S subunit of the ribosome.
  • HY-10392
    Sutezolid
    99.50%
    Sutezolid (PNU-100480), an orally active oxazolidinone antimicrobial agent, acts by inhibiting bacterial protein synthesis.
  • HY-14855B
    Tedizolid phosphate
    99.86%
    Tedizolid phosphate (TR-701FA) is a novel oxazolidinone with activity against Gram-positive pathogens.
  • HY-100436
    Cadazolid
    98.66%
    Cadazolid (ACT-179811) is a new oxazolidinone antibiotic with potent activity against Clostridium difficile.
  • HY-14800
    Radezolid
    99.27%
    Radezolid (RX-1741) is a oxazolidinone antibiotic.
  • HY-100180
    Delpazolid
    ≥98.0%
    Delpazolid is a novel oxazolidinone antibiotic agent which can inhibit the growth of MSSA and MRSA with a MIC90 of 2 μg/mL for both of them.
  • HY-19915
    Contezolid
    99.37%
    Contezolid (MRX-I), a new and orally active oxazolidinone, is an antibiotic in study for complicated skin and soft tissue infections (cSSTI) caused by resistant Gram-positive bacteria.
  • HY-10393
    Eperezolid
    Eperezolid(PNU-100592) is a oxazolidinone antibacterial agent, Eperezolid demonstrated good in vitro inhibitory activity, regardless of methicillin susceptibility for staphylococci(MIC90= 1-4 mg/ml).
  • HY-14855A
    (S)-Tedizolid
    (S)-Tedizolid is the S-enantiomer of Tedizolid.
  • HY-19915A
    Contezolid acefosamil
    Contezolid acefosamil (MRX-4) is the orally active prodrug of the active antimicrobial metabolite Contezolid (MRX-I), an oxazolidinone which shows potent in vitro activity against various multidrug-resistant Gram-positive bacteria, including MRSA.
  • HY-19915B
    Contezolid acefosamil sodium
    99.38%
    Contezolid acefosamil sodium (MRX-4), a new and orally active oxazolidinone, is an antibiotic in study for complicated skin and soft tissue infections (cSSTI) caused by resistant Gram-positive bacteria.
  • HY-122123
    S-6123
    S-6123 is a potent antimicrobial compound of the oxazolidinone series.
  • HY-15993
    Posizolid
    Posizolid (AZD2563), an oxazolidinone antibiotic, is developed by AstraZeneca for the study of bacterial infections.
  • HY-101726
    DuP 105
    DuP 105 is an orally active oxazolidinone, a new class of synthetic antimicrobial agent with activity against gram-positive bacteria.